Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California University of California San Diego (UCSD), San Diego, California University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma University of Virginia Cancer Center, Charlottesville, Virginia